PGPEP1, pyroglutamyl-peptidase I, 54858

N. diseases: 116; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.010 Biomarker phenotype BEFREE Inhibition of either microglial activation or CCR2 abolished the PAP-I-induced hyperalgesia. 31744864 2020
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.010 Biomarker phenotype BEFREE Thus, PAP-I mediates the neuron-microglial crosstalk after peripheral nerve injury, and contributes to the maintenance of neuropathic pain.<b>SIGNIFICANCE STATEMENT</b>Neuropathic pain is maladaptive pain condition and the maintaining mechanism is largely unclear. 31744864 2020
CUI: C0150055
Disease: Chronic pain
Chronic pain
0.010 Biomarker phenotype BEFREE Overall, the present analysis concludes changes in BPI average pain scores by PGI-I category and the cut-off for CID were similar for Asian and Caucasian patients with chronic pain due to osteoarthritis. 31505082 2020
CUI: C0751213
Disease: Tactile Allodynia
Tactile Allodynia
0.010 Biomarker phenotype BEFREE Intrathecal delivery of PAP-I enhanced sensory hyperalgesia, whereas PAP-I deficiency by either gene knockout or antibody application alleviated tactile allodynia at the maintenance phase after SNI. 31744864 2020
CUI: C0002871
Disease: Anemia
Anemia
0.010 Biomarker disease BEFREE The patients were randomly assigned into derivation cohort (801cases) and validation cohort (200 cases) in 8:2 ratio, respectively, in which in derivation cohort we found that 7 predictors, including LDH >350U/L, HR>130 times/min, room air PaO<sub>2</sub> <70mmHg, later admission to ICU, Anemia (HGB≤90g/L), CD4<50cells/ul, and development of a pneumothorax, were associated with poor prognosis in HIV/AIDS patients with PCP and were included in the predictive model. 30906778 2019
CUI: C0003175
Disease: Anthrax disease
Anthrax disease
0.010 Biomarker disease BEFREE According to our results, PCP-I could significantly enhance anthrax specific anti-PA antibodies, toxin-neutralizing antibodies, anti-PA antibody affinity, as well as IgG1 and IgG2a levels. 31809637 2019
CUI: C0020256
Disease: Congenital Hydrocephalus
Congenital Hydrocephalus
0.010 Biomarker disease BEFREE In this review we would like to discuss the data regarding p73 role as regulator of ependymal cell ciliogenesis and PCP, supporting the view of the <i>Trp73</i>-mutant mice as a model that uncouples ciliogenesis from PCP and a possible model of human congenital hydrocephalus. 30930930 2019
CUI: C0032326
Disease: Pneumothorax
Pneumothorax
0.010 Biomarker phenotype BEFREE The patients were randomly assigned into derivation cohort (801cases) and validation cohort (200 cases) in 8:2 ratio, respectively, in which in derivation cohort we found that 7 predictors, including LDH >350U/L, HR>130 times/min, room air PaO<sub>2</sub> <70mmHg, later admission to ICU, Anemia (HGB≤90g/L), CD4<50cells/ul, and development of a pneumothorax, were associated with poor prognosis in HIV/AIDS patients with PCP and were included in the predictive model. 30906778 2019
CUI: C0149931
Disease: Migraine Disorders
Migraine Disorders
0.010 Biomarker group BEFREE The Migraine Disability Assessment (MIDAS), Patient Global Impression of Severity (PGI-S), Patient Global Impression of Improvement (PGI-I), and migraine headache days (MHD) served as anchors. 30861580 2019
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.010 Biomarker phenotype BEFREE Betaine also showed a prophylactic effect on behavioral abnormality induced by PCP. 31255657 2019
CUI: C0334037
Disease: Intestinal metaplasia
Intestinal metaplasia
0.010 GeneticVariation phenotype BEFREE Compared with patients with extended AG/IM (PGI/II≤3 and/or OGLIM stage III-IV), patients with limited AG/IM (PG I/II>3 and OLGIM stage 0-II) did not develop high-grade adenoma/dysplasia or invasive neoplasia during follow-up (p=0.02). 29875257 2019
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 Biomarker disease BEFREE Herein, we have developed a two-photon probe (PCP-1) for selectively targeting and imaging the MAO-A in PCa. 31621760 2019
CUI: C0426359
Disease: Urinary symptoms
Urinary symptoms
0.010 Biomarker phenotype BEFREE The patients' Global Impression of Improvement (PGI-I) and quality of life index (QoL-I) due to urinary symptoms were used for outcome evaluation. 30083942 2019
CUI: C0497169
Disease: hiv-infection/aids
hiv-infection/aids
0.010 Biomarker disease BEFREE A predictive model to evaluate mortality in HIV/AIDS patients with PCP was constructed based on routine laboratory and clinical parameters, which may be a simple tool for physicians to assess the prognosis in HIV/AIDS patients with PCP in China. 30906778 2019
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 Biomarker disease BEFREE Herein, we have developed a two-photon probe (PCP-1) for selectively targeting and imaging the MAO-A in PCa. 31621760 2019
CUI: C0149678
Disease: Epstein-Barr Virus Infections
Epstein-Barr Virus Infections
0.010 AlteredExpression group BEFREE EBV infection in situ increased the serum levels of PGI and ratio of PGI/PGII in gastric cancer patients. 30053417 2018
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.010 Biomarker phenotype BEFREE Mice receiving PCP and saline exhibited deficits in novel object recognition, as expected, while pridopidine treatment counteracted PCP-induced memory impairment. 29692729 2018
CUI: C0542476
Disease: Forgetful
Forgetful
0.010 Biomarker phenotype BEFREE Mice receiving PCP and saline exhibited deficits in novel object recognition, as expected, while pridopidine treatment counteracted PCP-induced memory impairment. 29692729 2018
CUI: C0694571
Disease: extranodal lymphoma
extranodal lymphoma
0.010 GeneticVariation disease BEFREE Primary gastrointestinal non-Hodgkin's lymphoma (PGI NHL) is the most common type of extranodal lymphoma. 29764448 2018
Digestive System Non-Hodgkin Lymphoma
0.010 GeneticVariation disease BEFREE Primary gastrointestinal non-Hodgkin's lymphoma (PGI NHL) is the most common type of extranodal lymphoma. 29764448 2018
CUI: C2363741
Disease: HIV-1 infection
HIV-1 infection
0.010 Biomarker disease BEFREE Despite subsequent successful treatment of PCP and HIV-1 infection, we could not save her life due to the intracranial hemorrhage caused by Moyamoya syndrome. 29138020 2018
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 GeneticVariation disease BEFREE PGII levels increased while PGI/PGII declined with age in a healthy population.<i>H. pylori</i> infection had an effect on raising LDL-C levels to increase the risk of atherosclerosis in males, especially those of elderly age.Age, <i>H. pylori</i> infection, levels of renal function and FBG were associated with levels of pepsinogens and gastrin. 28932086 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 GeneticVariation disease BEFREE PGII levels increased while PGI/PGII declined with age in a healthy population.<i>H. pylori</i> infection had an effect on raising LDL-C levels to increase the risk of atherosclerosis in males, especially those of elderly age.Age, <i>H. pylori</i> infection, levels of renal function and FBG were associated with levels of pepsinogens and gastrin. 28932086 2017
CUI: C0008626
Disease: Congenital chromosomal disease
Congenital chromosomal disease
0.010 Biomarker group BEFREE GISTIC analysis of MIP data showed no significant larger chromosomal aberrations but a fraction of ACP showed recurrent focal gains of chromosomal material, other cases showed loss in the chromosomal region Xq28, and a third group and the PCP had stable genomes. 28069929 2017
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders
0.010 Biomarker group BEFREE We conclude that acute PCP induces SCZ-like symptom classes in a dose-dependent manner; PCP doses of 1.0-2.0 mg/kg are more suitable for modeling SCZ-like negative symptoms and cognitive deficits, while SCZ-like positive symptoms dominate at doses of 3.0-5.0 mg/kg. 28342897 2017